These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23469485)

  • 1. [Is there a place for the physician's hopelesness in the treatment of depression?].
    Pitchot W
    Rev Med Liege; 2013 Feb; 68(2):61-4. PubMed ID: 23469485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Goforth HW; Carroll BT
    J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
    [No Abstract]   [Full Text] [Related]  

  • 6. Aripiprazole as an adjunctive treatment for refractory major depression.
    Hellerstein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
    [No Abstract]   [Full Text] [Related]  

  • 7. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report.
    Sharma V; Sommerdyk C; Xie B
    Arch Womens Ment Health; 2015 Feb; 18(1):131-4. PubMed ID: 25223952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole adjunctive to antidepressant therapy.
    Marcus RM; Sanchez R; Frost M; McQuade RD
    Am J Psychiatry; 2011 Feb; 168(2):211; author reply 211. PubMed ID: 21297051
    [No Abstract]   [Full Text] [Related]  

  • 10. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
    Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is aripiprazole an efficacious adjunct for unipolar depression?
    Rakofsky JJ; Ghaemi SN
    J Clin Psychiatry; 2008 Jun; 69(6):1021; author reply 1021-2. PubMed ID: 18684004
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN
    Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe urinary retention requiring urinary catheterization associated with combined treatment of depression with duloxetine and quetiapine.
    Wang SM; Lee KU; Jeon YW; Park EJ; Han SI
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):191. PubMed ID: 23581874
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole-induced sialorrhea.
    Praharaj SK; Jana AK; Sinha VK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):384-5. PubMed ID: 19162120
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.
    Kemp DE; Dago PL; Straus JL; Fleck J; Karaffa M; Gilmer WS
    J Clin Psychopharmacol; 2007 Jun; 27(3):304-5. PubMed ID: 17502781
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.
    Trivedi MH; Corey-Lisle PK; Guo Z; Lennox RD; Pikalov A; Kim E
    Int Clin Psychopharmacol; 2009 May; 24(3):133-8. PubMed ID: 19318972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
    Sokolski KN; Gripeos D
    Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.